50419-542 : Kerendia 40 mg Oral Tablet
| NDC: | 50419-542 |
| Labeler: | Bayer Healthcare Pharmaceuticals Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: | Kerendia |
| Dosage Form: | Oral Tablet |
| Application #: | NDA215341 |
| Rev. Date: |
NDC Package Codes:
- 50419-542-01: 30 TABLET IN 1 BOTTLE, PLASTIC (50419‑542‑01)
- 50419-542-02: 90 TABLET IN 1 BOTTLE, PLASTIC (50419‑542‑02)
- 50419-542-06: 10 TABLET IN 1 BLISTER PACK (50419‑542‑06)
- 50419-542-70: 7 TABLET IN 1 BOTTLE, PLASTIC (50419‑542‑70)
Active Ingredients:
- Finerenone
Dosage Strength:
- 40 mg
Pharmaceutical Classes:
- Mineralocorticoid Receptor Antagonists [MoA]
- Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]
Related Products:
Based on records with the same trade name.- 50419-540 Kerendia 10 mg Oral Tablet, Film Coated by Bayer Healthcare Pharmaceuticals Inc.
- 50419-541 Kerendia 20 mg Oral Tablet, Film Coated by Bayer Healthcare Pharmaceuticals Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 50419-541Next: 50419-701 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.